Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental group:Lianhua Qingwen capsules/granules
Control group:Null
Sponsors
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Those who are confirmed to be in need of centralized medical isolation observation after the epidemiological investigation of the new coronavirus pneumonia. 2. Aged >=18 years, no gender limit. 3. Voluntarily sign an informed consent form before the start of the study (exemption is available if the ethics committee agrees to exempt subjects from signing informed consent).
Exclusion criteria
Exclusion criteria: 1. Those who have been identified as asymptomatic infection or confirmed cases of novel coronavirus pneumonia after etiological testing and clinical manifestations or signs. 2. Allergic constitution, such as those with a history of allergies to two or more drugs or foods, or those who are known to be allergic to the ingredients of this medicine. 3. There are serious systemic diseases or other special circumstances (pregnancy, lactation, mental disorders, etc.), and the investigator determines that it is not suitable to participate in clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The positive rate of nucleic acid test of nasal and throat swabs during the isolation medical observation period; | — |
Countries
China
Contacts
Public ContactNing Guang
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed